The Abstract: August 15, 2022

August 15, 2022
Hincapie-Castillo assesses COVID-19 dashboards in public schools, Rothenberg is named RTI International's Mentee of the Year and students from biostatistics are honored for research.

Gillings faculty complete innovative Round 6, COVID-19 GILs

August 12, 2022
Gillings faculty have recently completed four GILs, including two from Round 6 of GIL funding and two from the special COVID-19 round of funding. The results of their work have furthered our understanding of energy storage, brain health, environmental exposures, viral transmission, pandemic response and more.

The Abstract: July 25, 2022

July 25, 2022
Gillings researchers are recognized for work in pharmacoepidemiology, public health leadership and marine environmental sciences, and a recent alumnus receives outstanding dissertation honors.

Immune modulator drugs improved survival for people hospitalized with COVID-19

July 15, 2022
A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.

Preventative therapy for malaria has positive effect on baby birth weight, unless intestinal pathogens are present

June 29, 2022
Recently published in eBioMedicine, this study represents work that originated with the late Gillings School professor Dr. Steve Meshnick.

Removing Medicaid prescription restrictions could improve treatment for opioid use disorder

June 24, 2022
Removing the Medicaid requirement for prior approval to fill prescriptions for buprenorphine, a common treatment for opioid use disorder, could lead to more patients gaining access to this life-saving medication.

Weber publishes 50th paper about coronaviruses and COVID-19

June 23, 2022
Infectious disease expert Dr. David Weber has reached a formidable hallmark: his 50th publication about coronaviruses and COVID-19. His research has played an important role in creating new policies and ways that we can keep ourselves and patients safe in community and hospital settings.

Grant explores little-understood effects of wildfire smoke

June 16, 2022
A new study from recent MPH@UNC graduate Emilly Grant assesses what scientists currently know about the long-term health effects of wildfire exposure – and what they don’t. Her findings underscore an urgent need for greater scrutiny of these health impacts in the face of growing risk from devastating wildfires that are increasing in frequency.

The missing diversity in human epigenomic studies

June 9, 2022
Researchers discuss the lack of diversity in epigenomic studies, which undermines scientists’ ability to understand the causes and risks of disease in different groups of people.

Researchers develop app to detect neglected tropical disease affecting millions of people worldwide

June 2, 2022
The new technology is estimated to detect cases of trachomatous trichiasis with 92% accuracy.

...
5
6
7
1
3
4
8
9
10
11
29
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400